Seaport Therapeutics, Inc. (SPTX) stock
SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 2, 2026
$18.17−0.95 (-4.97%)
Close on Nov 17, 2026Market cap $972.65MP/E –Yield –
Seaport Therapeutics EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$0.49 | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.78 | – |
| Q1 FY2026 | Mar 31, 2026 | -$10.34 | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.43 | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.40 | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.65 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?